LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹13 Cr | ₹11 Cr | ₹7.94 Cr | ₹6.46 Cr | ₹5.69 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹7.94 Cr |
| Mar2022 | ₹6.46 Cr |
| Mar2021 | ₹5.69 Cr |
How is Deferred Tax Assets / Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 13.50 | |
| Mar2024 | ₹11 Cr | 44.26 | |
| Mar2023 | ₹7.94 Cr | 23.02 | |
| Mar2022 | ₹6.46 Cr | 13.42 | |
| Mar2021 | ₹5.69 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,231.1 Cr | 0.6% | 7.6% | 11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 0.6% |
7.6% |
11.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses